Mattia Galli: Sex-related Differences in Platelet Reactivity in Patients Both On and Off Antiplatelet Therapy
Mattia Galli, Assistant Professor at Sapienza Università di Roma, Associate Editor of European Heart Journal, shared a proud post on LinkedIn:
”Sex-related differences in platelet reactivity are emerging as a relevant factor in patients both on and off antiplatelet therapy.
In these two recent contributions, published almost simultaneously, we present evidence from both randomized controlled trials and the largest pharmacodynamic study in this setting to date, suggesting that females may benefit from antiplatelet regimens different from those typically used in males.
This represents another important step forward in advancing precision medicine in cardiology.”
Read the full articles in European Heart Journal and EHJ Cardiovascular Pharmacotherapy.
Article 1: Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysis
Authors: Giovanni Occhipinti , Claudio Laudani , Mattia Galli , Luis Ortega-Paz , Vijay Kunadian , Guiomar Mendieta , Riccardo Rinaldi , Felicita Andreotti , Roxana Mehran , Teresa López-Sobrino , Davide Capodanno , Dominick J Angiolillo , Manel Sabaté Tenas , Salvatore Brugaletta
Article 2: Sex-related variations in platelet reactivity in presence or absence of antiplatelet therapy
Authors: Mattia Galli , Sergio Terracina , Eleonora Schiera , Simone De Corci , Diego Sangiorgi , Massimo Mancone , Luigi Frati , Sebastiano Sciarretta , Dominick J Angiolillo , Fabio M Pulcinelli
Stay updated on all science in the field of platelet disorders with Hemostasis Today.
-
Aug 20, 2025, 15:36Antoine Francis: LIFE - The Only Metric
-
Aug 20, 2025, 15:09World Stroke Academy: Rodrigo Guerrero Torrealba on Acute Vestibular Syndrome and Stroke
-
Aug 19, 2025, 14:27Living With a Blood Clot? Join NBCA’s Free PEP Talk for Support
-
Aug 19, 2025, 14:23EHC 2025: Young Voices Shaping the Future of Bleeding Disorders
-
Aug 19, 2025, 14:20Prakash Upreti: ECMO in High-Risk Pulmonary Embolism
-
Aug 20, 2025, 14:25Mattia Galli: Sex-related Differences in Platelet Reactivity in Patients Both On and Off Antiplatelet Therapy
-
Aug 20, 2025, 12:55Commentary from Giuseppe Lippi and Colleagues on Light Exposure, Platelet Function and Thrombus Formation
-
Aug 20, 2025, 05:48James Harte on Asundexian and Milvexian's Strong, Dose-dependent Interferences in Coagulation Assays
-
Aug 19, 2025, 18:18Hélène Gleitz-Broeders: Targeting Stromal Crosstalk to Reverse Bone Marrow Fibrosis
-
Aug 19, 2025, 17:58David Tregouet on Molecular Determinants of Thrombosis Recurrence Risk Across VTE Subtypes
-
Aug 18, 2025, 23:56Dr. Arun V. J Invites You to His Lecture on ‘AI and Data Sciences in Transfusion Medicine’ at the AI in Healthcare Conclave. Register now!
-
Aug 18, 2025, 23:50Safe and Efficient Thrombectomy with Artix System: Clinical Insights from Neil Desai and Colleagues
-
Aug 16, 2025, 14:42Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Aug 20, 2025, 13:33Askat's Life with Hemophilia A after Access to Prophylactic Treatment Through the WFH Humanitarian Aid Program
-
Aug 19, 2025, 17:22Louise Bannon Encourages You to Support World Thrombosis Day!
-
Aug 17, 2025, 07:31Melissa Korn's story: Recognizing Pulmonary Embolism Symptoms Can Save Lives, NBCA
-
Aug 16, 2025, 14:18Christelle Orlando Highlights Breakthroughs in Thrombophilia Testing and AT Assays at ISTH 2025
-
Aug 15, 2025, 23:33Kacper Odziomek Excels in 2 Pharmacology Courses from Harvard Medical School